Thomson Reuters' Clinical Xpert Navigator named in KLAS Awards

NewsGuard 100/100 Score

Thomson Reuters announced today that its Clinical Xpert((TM)) Navigator has been named the category leader for mobile data systems in the latest "Top 20 Best in KLAS Awards: Software & Professional Services" report.

This is the eighth consecutive year that the Navigator solution (formerly MercuryMD MData) has been ranked number one.

Clinical Xpert Navigator received higher scores than the competition in virtually every major category evaluated by KLAS, a research firm that monitors and reports on the performance of healthcare technology vendors.

Navigator outpaced other mobile solutions by receiving a "product quality" rating of 8.28 on a nine-point scale -- placing it in the top 5 percent of all software solutions cited in the report. It also received a score of 97 percent in a key category: customers indicating they would buy the solution again.

"By collecting the opinions of healthcare executives, managers, and clinicians, KLAS offers an impartial view of how well IT vendors are meeting provider expectations," said Jason Hess, general manager, clinical research for KLAS Research. "Thomson Reuters customers continue to show their satisfaction with Clinical Xpert Navigator by again rating it the category leader for mobile data systems."

"This is a gratifying recognition from our customers that our mobile clinical solutions -- and the support we provide for them -- are delivering a high level of satisfaction," said Thomas Hegelund, executive vice president for the Healthcare & Science business of Thomson Reuters.

SOURCE Thomson Reuters

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis